58 related articles for article (PubMed ID: 9696025)
1. Clinical outcome of hepatitis C as a function of mode of transmission.
Gordon SC; Bayati N; Silverman AL
Hepatology; 1998 Aug; 28(2):562-7. PubMed ID: 9696025
[TBL] [Abstract][Full Text] [Related]
2. Platelet transfusion in patients with liver cirrhosis cross-talk with neutrophil: Prospective study.
Hassouna MM; Mostafa MS; Omar HM; Mohammed EA; Abdallah HM
Hematol Transfus Cell Ther; 2023; 45(4):461-466. PubMed ID: 36813682
[TBL] [Abstract][Full Text] [Related]
3. Cirrhotic patients and older people.
Carrier P; Debette-Gratien M; Jacques J; Loustaud-Ratti V
World J Hepatol; 2019 Sep; 11(9):663-677. PubMed ID: 31598192
[TBL] [Abstract][Full Text] [Related]
4. Predictors of survival among patients with chronic hepatitis C at a tertiary care center in Oman.
Al-Shuaili HH; Al-Busafi SA; Al-Naamani K; Al-Naamani Z
Saudi J Gastroenterol; 2024 Jan; 30(1):45-52. PubMed ID: 38190454
[TBL] [Abstract][Full Text] [Related]
5. Dose-Dependent Hepacivirus Infection Reveals Linkage between Infectious Dose and Immune Response.
Gömer A; Delarocque J; Puff C; Nocke MK; Reinecke B; Baumgärtner W; Cavalleri JMV; Feige K; Steinmann E; Todt D
Microbiol Spectr; 2022 Oct; 10(5):e0168622. PubMed ID: 35993785
[TBL] [Abstract][Full Text] [Related]
6. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment.
Tarao K; Nozaki A; Ikeda T; Sato A; Komatsu H; Komatsu T; Taguri M; Tanaka K
Cancer Med; 2019 Mar; 8(3):1054-1065. PubMed ID: 30791221
[TBL] [Abstract][Full Text] [Related]
7. Is the 25-year hepatitis C marathon coming to an end to declare victory?
Ahmed KT; Almashhrawi AA; Ibdah JA; Tahan V
World J Hepatol; 2017 Jul; 9(21):921-929. PubMed ID: 28824743
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategies for chronic hepatitis C prior to and following liver transplantation.
Perumpail RB; Hahambis TA; Aggarwal A; Younossi ZM; Ahmed A
World J Hepatol; 2016 Jan; 8(1):69-73. PubMed ID: 26783422
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.
Smith DJ; Combellick J; Jordan AE; Hagan H
Int J Drug Policy; 2015 Oct; 26(10):911-21. PubMed ID: 26298331
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study.
Gordon SC; Lamerato LE; Rupp LB; Holmberg SD; Moorman AC; Spradling PR; Teshale E; Xu F; Boscarino JA; Vijayadeva V; Schmidt MA; Oja-Tebbe N; Lu M
Am J Gastroenterol; 2015 Aug; 110(8):1169-77; quiz 1178. PubMed ID: 26215529
[TBL] [Abstract][Full Text] [Related]
11. Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection.
Tokunaga M; Uto H; Oda K; Tokunaga M; Mawatari S; Kumagai K; Haraguchi K; Oketani M; Ido A; Ohnou N; Utsunomiya A; Tsubouchi H
J Gastroenterol; 2014 Dec; 49(12):1567-77. PubMed ID: 24463696
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hepatitis C virus replication by nuclear translocation of nonstructural 5A protein and transcriptional activation of host genes.
Maqbool MA; Imache MR; Higgs MR; Carmouse S; Pawlotsky JM; Lerat H
J Virol; 2013 May; 87(10):5523-39. PubMed ID: 23468497
[TBL] [Abstract][Full Text] [Related]
13. Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies.
Mair RD; Valenzuela A; Ha NB; Ayoub WS; Daugherty T; Lutchman GA; Garcia G; Ahmed A; Nguyen MH
Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1412-7. PubMed ID: 22902757
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in patients with autoimmune hepatitis.
Teufel A; Weinmann A; Centner C; Piendl A; Lohse AW; Galle PR; Kanzler S
World J Gastroenterol; 2009 Feb; 15(5):578-82. PubMed ID: 19195059
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E
World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937
[TBL] [Abstract][Full Text] [Related]
16. Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study.
Hajiani E; Hashemi J; Masjedizadeh R; Shayesteh AA; Idani E; Rajabi T
World J Gastroenterol; 2006 Aug; 12(30):4884-7. PubMed ID: 16937474
[TBL] [Abstract][Full Text] [Related]
17. The natural history of hepatitis C virus (HCV) infection.
Chen SL; Morgan TR
Int J Med Sci; 2006; 3(2):47-52. PubMed ID: 16614742
[TBL] [Abstract][Full Text] [Related]
18. Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States.
Hu KQ; Yang H; Lin YC; Lindsay KL; Redeker AG
Int J Med Sci; 2004; 1(2):92-100. PubMed ID: 15912201
[TBL] [Abstract][Full Text] [Related]
19. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.
Mohsen AH; Easterbrook PJ; Taylor C; Portmann B; Kulasegaram R; Murad S; Wiselka M; Norris S
Gut; 2003 Jul; 52(7):1035-40. PubMed ID: 12801963
[TBL] [Abstract][Full Text] [Related]
20. Natural history of hepatitis C infection: a concise review.
Lim JK
Yale J Biol Med; 2001; 74(4):229-37. PubMed ID: 11697481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
